SEGMENT AND GEOGRAPHIC INFORMATION

In October 2017, the Company leveraged the globally recognized Codman name by rebranding the Specialty Surgical Solutions segment as Codman Specialty Surgical.

The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.

•

The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the precision tools and instruments business, which sells more than 60,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.


•	The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts and nerve and tendon repair products.

The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.

The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by reportable segment for the three and nine months ended September 30, 2018 and 2017 are as follows:



	Three Months Ended September 30,						Nine Months Ended September 30,
	2018			2017			2018		2017
	(In thousands)
Segment Net Sales
Codman Specialty Surgical	$	239,035		$	164,760		$	714,654	$	480,907
Orthopedics and Tissue Technologies	126,819			114,074			374,472		338,727
Total revenues	$	365,854		$	278,834		$	1,089,126	$	819,634
Segment Profit
Codman Specialty Surgical	$	91,871		$	68,289		$	272,480	$	198,242
Orthopedics and Tissue Technologies	35,515			30,411			105,094		88,500
Segment profit	127,386			98,700			377,574		286,742
Amortization	(5,268		)	(5,456)			(15,944)		(14,976)
Corporate and other	(98,441		)	(82,602		)	(284,740)		(234,180		)
Operating income	$	23,677		$	10,642		$	76,890	$	37,586

The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.

The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:



	Three Months Ended September 30,				Nine Months Ended September 30,
	2018		2017		2018		2017
	(In thousands)
United States	$	260,870	$	213,685	$	769,509	$	634,047
Europe	47,472		32,609		150,650		93,924
Asia Pacific	37,022		16,887		108,304		48,540
Rest of World	20,490		15,653		60,663		43,123
Total Revenues	$	365,854	$	278,834	$	1,089,126	$	819,634